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The foundation of homeopathic medicine is the ‘Similia Principle’, also known as the ‘Principle
of Similarity’ or also as the ‘Simile’, which reflects the inversion of pharmacological effects in
healthy subjects as compared with sick ones. This article describes the inversion of effects, a
widespread medical phenomenon, through three possible mechanisms: non-linearity of dose–
response relationship, different initial pathophysiological states of the organism, and
pharmacodynamics of body response to the medicine. Based on the systemic networks which
play an important role in response to stress, a unitary and general model is designed:
homeopathic medicines could interact with sensitive (primed) regulation systems through
complex information, which simulate the disorders of natural disease. Reorganization of
regulation systems, through a coherent response to the medicine, could pave the way to the
healing of the cellular, tissue and neuro-immuno-endocrine homeodynamics. Preliminary
evidence is suggesting that even ultra-low doses and high-dilutions of drugs may incorporate
structural or frequency information and interact with chaotic dynamics and physical-
electromagnetic levels of regulation. From the clinical standpoint, the ‘simile’ can be regarded
as a heuristic principle, according to which the detailed knowledge of pathogenic effects of
drugs, associated with careful analysis of signs and symptoms of the ill subject, could assist
in identifying homeopathic remedies with high grade of specificity for the individual case.
Keywords: action–reaction principle – biologic networks – homeopathic medicine – hormesis –
inverse effects – paradoxical pharmacology – response to stress – self-organization – Similia
principle –Wilder’s rule
Introduction
The cardinal principle on which the theory of homeo-
pathic medicine is based is that of ‘similarity’, according
to which a homeopathic remedy in a healthy subject
will produce certain sets of symptoms, while the same
remedy will cure similar sets of symptoms in unhealthy
(sick) subjects (1–3). Hahnemann’s theory withstands the
test of time, and has been supported by scientific findings
in an array of fields, including that of immuno-
allergology, as described in previous lectures on the
subject (4–7). This principle can now be integrated into a
broad theory of the homeodynamics of living systems
(Table 1).
Indeed, there is a need for viable hypotheses of
homeopathy mechanism of action. One of the earliest
systematic reviews of homeopathic clinical trials con-
cludes: ‘. . .The amount of positive evidence even among the
best studies came as a surprise to us. Based on this
evidence we would readily accept that homeopathy can be
efficacious, if only the mechanism of action were more
plausible’ (8).
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Another controversial principle of homeopathy is that
the strength of a remedy would be increased through
its dilution, which is a process known as dynamization, or
potentization. At the end of this report, we will briefly
discuss this issue. In any event, there is the need to clarify
a preliminary assumption: both molecular and non-
molecular information (i.e. mechanic, acoustic, electro-
magnetic, quantum electrodynamic) operate biologically,
and regulation through the ‘simile’ could work in both
cases, since they are not conflicting one with the other.
The purpose of this lecture is to re-evaluate the
principle of similarity through up-to-date scientific
knowledge concerning many phenomena, from cell
behavior to clinical practice (9–11). This will allow us
to extrapolate a general working hypothesis according to
which biologically active compounds (including highly
diluted solutions) could have inverse or paradoxical
effects, based on one or a combination of the following
factors:
(a) non-linearity of response to different doses of the
compound/signal,
(b) pathophysiological state of the treated organism
and
(c) pharmacodynamics of the drug, particularly with
regard to the rebound effects and long-term
adaptation.
Non-linearity of the Dose–Response
In biological systems, non-linearity between dose and
effect is the rule, rather than the exception. Even if this
phenomenon does not clarify all the clinical effectiveness
of homeopathy, the following controlled experimental
models examine the similia principle.
Hormoligosis
The terms ‘hormoligosis’ and ‘hormesis’ refer to stimula-
tion of biological systems by low-dose toxins and
inhibitors, as shown in a number of experimental
models (12–20). Early attempts to describe hormesis
date back to 1877 when Schulz, while studying yeast
metabolism, proved that almost all poisons have a weak
stimulus effect at low doses (21,22). Together with
R. Arndt, he then developed a principle, the so-called
‘Arndt-Schulz law’: ‘weak stimuli slightly increase
biological responses, medium–strong stimuli markedly
raise them, strong ones suppress them and very strong
ones arrest them’ (23).
In general, these hormetic effects can be documented
by reverse-U dose–response plots or even more complex
dose–response curves. In Fig. 1A, a typical hormetic
(reverse-U shaped) curve is shown. Figure 1B shows the
kinetic of low-dose and high-dose effects of inhibitors on
a biological system: an overcompensatory response
follows the initial decrease in activity due to inhibitor
low doses. This may optimize the ability of an organism
to meet challenges beyond the limits of normal
(unexercised) adaptation.
Inhibition by Low Doses
A wide variety of substances exert opposing effects
(inhibitory or stimulating) at low or high doses; this
phenomenon is well documented in immunology.
Figure 1C shows how specific antibody levels can
change in mice inoculated with different antigen (bovine
serum albumin) doses. At low or high antigen doses,
the murine immune response is depressed (immune-
tolerance), while there is a positive antibody-production
response at intermediate doses.
Various factors contribute to the result, in conjunction
with specific lymphocyte subset activation, different
receptor sensitivities and the role of the tissue environ-
ment on the cell activation/suppression. At least two
different mechanisms are responsible for T-cell auto-
reactivity: high concentration of self-antigens causes cell
depletion, while low doses cause a specific inhibition,
known as bystander suppression. This low-dose regula-
tion could be used to explain the effects of some
homeopathic medicines (24). However, even with much
scientific evidence, the concept of hormetic dose–response
relationship is not integrated by mainstream schools
of thought in toxicology (25).
Table 1. The homeopathic simile and regulation of body homeodynamics
(a) Homeopathy is a therapeutic method based on the application of the similia principle, utilizing medicinal substances that, in healthy subjects,
produce effects that are similar to the symptoms being treated in ill subjects.
(b) When a healthy organism is perturbed by every physical, chemical, or biological stressor, it produces characteristic signs and symptoms; when
caused by a drug, this is regarded as an expression of iatrogenic response or pathophysiological reaction (‘proving’ in the homeopathic medical
system).
(c) The provings that describe the characteristic patterns of signs and symptoms, caused in healthy subjects by a number of mineral, vegetable and
animal compounds, have been gathered during the past two centuries in the homeopathic ‘Materia Medica’.
(d) When threatened by natural disorder or disease, living organisms show signs and symptoms which are mainly the expression of the efforts to
re-establish normal homeodynamics at cellular, tissue and systemic levels including the mind. In chronic conditions, the symptoms also reflect
the failure of those efforts, the blockade of regulation system(s), and the pathological adaptation to the disease.
(e) Low doses or high dilutions of a substance which is capable of evoking certain symptoms in healthy subjects, when administered to subjects
showing similar symptoms due to natural diseases, may evoke a specific and global secondary healing reaction, thus becoming a potentially
effective therapeutic agent.
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Inverse Effects in a Leukocyte Model
The activation of human neutrophils shows a dose-
dependence on bacterial peptides (Fig. 1D) (26,27). High
doses (106–107M) of bacterial peptides formyl–
Methionyl–Leucyl–Phenylalanine (fMLP) were able to
induce a marked increase in adhesiveness of human
leukocytes, whereas 100 times lower doses (108–109M)
inhibited and reversed the adhesion induced by bacterial
endotoxin (LPS) (28) or by migration into the inflam-
matory exudate (29).
This paradoxical effect of low-dose fMLP models is
probably due to the ‘gating’ exerted by cyclicAMP
(cAMP) at the level of intracellular signal transduction
pathways (26). Figure 2 shows a schematic representation
of a LPS-treated cell, with no fMLP (A), and low (B) and
high (C) doses of fMLP. The latter bacterial peptide at
low doses does not stimulate adhesion, whereas the
intracellular cAMP increases, through activation of
adenylate cyclase. cAMP is an intracellular messenger
for many enzymes, including protein kinase A which, in
turn, can inhibit the LPS-activated transduction machin-
ery of adhesion (gating pathway). fMLP at high doses
obtains full activation, using a different transduction
pathway (represented in Fig. 2 by squares), thus
by-passing the gating by cAMP.
The importance of cAMP has also been invoked
in explaining other phenomena which recall the
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Figure 1. Examples of biphasic or polyphasic dose–response curves.
eCAM 2007;4(2) 151
‘simile’: interleukin-2 has opposite effects on B lympho-
cytes depending on intracellular cAMP levels (30); the
inhibition of basophil responses by low doses (31) or high
dilutions (32) of natural compounds may have a similar
explanation at the level of signal transduction.
Furthermore, not only the gating theory explains the
occurrence of inverse effects at a cell level: the presence of
various receptors with both different affinities and
different coupling capabilities to effector systems, or the
induction of detoxification enzymes (gene expression and
enzyme activation) should also be considered (33). Other
authors (34–39) have elaborated different theories, based
on the heat-shock protein system activation, or on the
metabolism regulation and on toxicology. Those theories
do not conflict with each other, but concern different
levels of cell organization.
The Role of Pathophysiological State
The role of inflammatory processes is to control
the structural integrity of organs and tissues, while the
immune system controls the specific identity, or biologi-
cal ‘selfness’, of molecules within the organism. Those
systems are integrated with the peripheral and central
nervous systems (40): mood and behavior disorders
are associated with immunopathological disorders, with
susceptibility to recurring infection, hypersensitivity,
allergies, autoimmune diseases and diabetes. Homeo-
pathic therapy should act by regulating the inflammatory
and immune systems, both directly through molecular
similarity, as seen in isopathic therapies, and indirectly
through systemic interconnections, as shown in Fig. 3.
The Response To Stress
Figure 3A shows a typical sequence of physiological
mechanisms which maintain homeodynamics in the
immune and endocrine systems. Psychosocial stressors
activate the neuroendocrine pathways which, eventually,
can lead to higher corticosteroid levels; uninterrupted
strong stimulation can suppress the immune system, thus
increasing susceptibility to infection (41,42). On the other
hand, peripheral inflammatory cells are recruited and
activated to counteract chemical or biological stress,
producing molecular messages (cytokines) toward the
central nervous system to build up a neuroendocrine
response to stress. Increased steroid production, in
conjunction with adrenergic stimulation, is important
in a wide variety of adaptive responses, including
regulation of inflammatory processes.
Repeated biological or physiological stress can cause
internal communication failures, leading to the adapta-
tion to a pathological state, more specifically, to chronic
disease. Figure 3B depicts a typical loss of sensitivity to
cytokines or to steroids. A variety of diseases are based
on the lack of adaptability to environmental change
through system or sub-system derangement. Immuno-
deficiency syndrome, atopic dermatitis, encephalomyeli-
tis, coronary artery disease, chronic heart failure, anxiety
and depression all exhibit an altered coordination or
disruption of neuro-endocrine signaling. For example,
glucocorticoid overproduction, combined with depression
and chronic stress, cause destabilization in the gluco-
corticoid receptors to the feedback inhibition of the
hypothalamus–pituitary–adrenal (HPA) axis and to an
increase of inflammatory cytokines (43). Some chronic
diseases, such as asthma, are considered as a type of
pathologic adaptation of complex networks, which
behave like semi-stable ‘attractors’ within the organism
(11,44). This self-maintenance of disease, as organization
of pathologic attractors in complex systems, can be
regarded as an update to the ‘miasm’ concept of classic
homeopathy (11,45–47).
The above theoretical background suggests that
homeopathic medicine can regulate inflammatory and
immunopathological processes as well as the neuroendo-
crine network and peripheral receptors. Homeopathic
information mimics a pathophysiological stress, because
it is able to induce symptoms of pathology, and, in
Figure 2. Schematic representation of the inverse effects of different doses of fMLP on LPS-treated human neutrophils.
152 Immunology and homeopathy
the ‘already-stressed’ and inefficient organism, would
re-activate a coherent response. In fact, homeopathy
could have a positive effect on stress-induced behavior
and on gastric and immunologic alterations in mice (48).
Highly diluted histamine shows to be active on blood
basophils, on skin inflammation reactions and on sleep
patterns in rats (5,49).
The ‘Initial Value’ Rule
Biological responses strictly depend on the ‘starting
conditions’ of any tissue or organ, and different starting
conditions yield peculiar reverse responses to a drug.
An example of different effects due to different cellular
conditions can be found in macrophages—these cells are
known to be activated, for example, by cytokines in
a number of biological events including chronic inflam-
matory reactions, tumor defense, repair phenomena,
atherosclerosis and so on. Interferons, endotoxins and
tumor-necrosis factors (TNFs) increase resting macro-
phage functional capability, whereas they suppress
previously activated macrophages (50). A related phe-
nomenon was described by Wilder in the first decades of
the past century in experimental settings (2,51,52).
A typical report of Wilder’s findings is shown in Fig. 4.
He recorded heart frequency and blood pressure
(not shown in the figure) in dogs before and after the
administration of 1mg adrenalin.
Under normal conditions (Fig. 4, line 1) the drug
causes an increase in both heart rate and blood pressure;
these then plateau and finally revert to the resting state.
Figure 3. Typical neuroimmunoendocrine networks involved in the response to any type of stress (A) and possible dysfunction in chronic
inflammatory diseases (B). 1. Cognitive functions, 2. neural networks, 3. hypothalamus, 4. locus ceruleus, 5. hypophysis, 6. sympathetic nervous
system (adrenergic), 7. adrenals, 8. cardiovascular system, 9. immune system and inflammatory processes. ACTH, adrenocorticotropic hormone;
CRH, corticotropin-releasing hormone; IL-1, interleukin-1; IL-6, interleukin-6; TNF, tumor–necrosis factor; ! stimulation,
Figure 4. Diagram of the effects of adrenaline (epinephrine) on
the cardiovascular system (the ‘initial value’ rule of Wilder).
For explanation, see text.
eCAM 2007;4(2) 153
This kinetic is due to the activation threshold of
homeodynamic feedback response, conceivably due to
vagus stimulation and to the inactivation of the
stimulant. However, when the initial heart rate is elevated
(high sympathetic tone of the test animal), the exogenous
adrenaline response is different—the initial increase is
less, prior to returning to the resting state (line 2).
Thus, the net effect of the drug is the decrease in heart
rate when compared with the initial rate. Starting with
very low heart rate (vagotonic state, line 3), the response
to adrenaline is higher than in normal animals, due to
the system’s higher sensitivity to the drug and to a
slower homeodynamic feedback threshold.
In humans, bronchial asthma is characterized by the
increase of vagus activity on smooth bronchial muscu-
lature; under these conditions, adrenaline supports
breathing, thanks to its dilating and relaxing effects. On
the other hand, in normal subjects, adrenalin has little
or no effects. In conclusion, the same treatment or similar
treatments can cause different, if not opposite, effects,
depending on the initial state of the system. This typical
behavior has been described in different physiological
systems (cardiovascular, hormonal, respiratory, nervous,
etc.) and using various drugs (53,54).
More recently, a preliminary mathematical model of
the action–reaction principles was developed looking at
the ‘weak quantum theory’ and the ‘patient–practitioner
entanglement’, based on the metaphor of a hypothetical
gyroscope as physical representation of the vital force
(55). Briefly, increase or decrease in the rate of spin of
a hypothetical gyroscope (namely the ‘vital force’) was
described in terms of quantized ‘shift operators’ con-
structed mathematically from the ‘complementarity’ of
a remedy’s primary and secondary symptoms. Therefore,
the vital force was studied as a ‘wave function’ able
to illustrate the biphasal action of remedies encapsulated
in the Arndt–Schulz law, Wilder’s law of initial value
and some of the results of homeopathic provings.
Rebound Effects and Paradoxical
Pharmacology
Inverse drug effects are evident by changing their
schedule or treatment duration, or the observation
period of the therapy: short treatment can be stimulating,
whereas longer treatment can be inhibitory (or opposite,
based on the experimental model). This area includes the
so-called ‘paradoxical pharmacology’ (56): chronic and
acute treatments produce opposite effects, similar to
those of a single physical exercise, which will increase
blood pressure, whereas ongoing training will regulate it.
Obvious evidence of these phenomena is observed in
receptor-mediated events and in heart failure progression:
the time-course of b-blocker treatment during heart
failure can be described as an immediate worsening of
the patient, whose condition then improves, with a net
result of a decrease in death by heart failure in the long
term. This paradox can be described in terms of beta-
receptor protection from overexposure, which is a
phenomenon generally associated with desensitization
and decreased signaling.
In addition to analgesia, opioids cause hyperalgesic
effects, depending on whether treatment is acute or
chronic, which have many clinical implications (57).
Antiepileptic drugs can frequently aggravate epilepsy by
way of an inverse pharmacodynamic effect (58).
The same secondary reaction of the organism can be
described for hundreds of modern drugs, including
antiinflammatory agents (59), and can be referred to as
the rebound effect. The drug’s primary effect forces the
organism toward a reaction against its own upsets by
way of a vital (paradoxical, secondary or compensating)
reaction.
If acute and chronic responses are often opposite in
nature, and if the drug’s counter-indications are based on
its acute effects, it is possible to find scientific input
to study paradoxical pharmacology—the list of drug
contra-indications, since ‘the opposite of contraindicated is
indicated . . .’ (56). A rapid initial decline may produce
long-term beneficial effects (60,61). Therefore, paradox-
ical and rebound effects could be considered curative,
thus allowing a connection between homeopathic ‘simile’
and traditional pharmacology (62).
General Model of the ‘Simile’
Having analyzed a few possible applications of the
‘similarity’ in biological systems, we will now describe a
general model of this core principle of homeopathy.
In previous studies (10,11,27,63), the concept of ‘regula-
tion of stressed homeodynamic networks’ was introduced,
based on how the networks react to stress, and on the
possible role of homeopathic self-recovery regulation.
Here we summarize and update this conceptual model,
which can help rationalize the basic mechanisms of
homeopathic simile on different levels of biological
organization (molecular, cellular, organic and systemic).
Homeodynamics of Biological Systems
The concept of homeostasis (more correctly referred
to as ‘homeodynamics’), introduced by physiologist
W. B. Cannon (64), refers to those activities which tend
to maintain the variables of a vital system constant,
or within acceptable limits. Hahnemann himself based his
medical system on the action and reaction principle.
In paragraph 3 of the ‘Organon’, he describes this
fundamental principle: ‘Every agent that acts upon
vitality, every medicine, deranges more or less the vital
force, and causes a certain alteration in the health of the
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individual for a longer or a shorter period. This is termed
primary action. To its action our vital force endeavours to
oppose its own energy. This resistant action is a property,
it is indeed an automatic action of our life-preserving
power, which goes by the name of secondary action or
counteraction’.
The Feed-back is the Core of Homeodynamics
To illustrate homeodynamic concepts, it is best to refer
to the simple model in Fig. 5A. We will consider the
variable A–A0 in a state of imbalance and in reversible
conditions due to the actions of two operator or effector
mechanisms, which can move A towards A0 and vice
versa. We refer to A as the normal condition and A0 as a
far-from-equilibrium (stressed, or diseased) condition.
No homeodynamic variable can properly function without
a form of control, represented by one or more regulatory
systems which receive information from A0 in the form of
signal ‘a’, which is associated with its specific state
(for example, an enzyme reaction product proportional
to how much of A0 is present or to how much of A0 is
functioning). Having received the ‘a’ signals (for which
it has specific receptors), the control system is activated
and produces the ‘r’ signal, which inhibits the A–A0
conversion, or activates the A0–A conversion. Figure 5A
illustrates that the signals are considered capable of
affecting other systems or other effector mechanisms, in
the same way as the regulatory system can have different
receptors which bind different active signals. Therefore, all
homeodynamic systems are included in a broad network
built on multiple elements. The model in this figure is
simplified; in fact, it only shows the central feed-back
structure of the complex biological homeodynamics.
The Reaction Phase
When a perturbing factor comes into play, the balance
shifts to A0 (Fig. 5B) and an increase of the ‘a’ signal
occurs. The regulatory system, in turn, enhances its own
activity, thus producing a higher quantity of the
‘r’ signal. For example, if ‘a’ is a signal molecule
(e.g. interleukin-1, cytokines, interferons) released from
inflammatory exudate, the immune system produces more
‘r’ signal (e.g. antibodies, interleukin-2), thus bringing the
effector system (phagocytes or complement) back to
its normal homeodynamic, by eliminating A0 excess and
re-establishing A condition (healing). In the initial phase
of disease, the system reacts logically and efficiently in
the direction of balance and health. Of course, if ‘a’
signal was an inhibitor, the A–A0 perturbation would be
followed by decrease of regulatory system’s function
(not described in the figure).
As shown in Fig. 5B, symptoms will appear when
physiologic systems are under stress, far from the
equilibrium. Symptoms are associated with endogenous
regulatory system activation (or inhibition), more than
with the direct damage due to the stressor/pathogenic
factor. In infectious diseases, for example, fever, fatigue,
loss of appetite, tachycardia and skin rashes are the
product of the organism’s reaction, primarily due to
molecular signals, such as complement factors, kinins,
interleukin-6, adrenalin and TNF.
Generally speaking, the initial response of a regulatory
system is associated with the priming of its own sensitivity
with respect to the signal, represented in Fig. 5B as an
increase in the number of surface receptors within
the system. This pre-activation was described by us in
leukocytes as ‘homologous priming’ (65) and may also
involve increase of receptor sensitivity or of signal
transduction. However, priming is usually not specific,
owing to the increase of sensitivity also to other stimuli
(heterologous priming), here represented as the exposure
of new receptors by the regulatory system for substances
other than ‘a’. This event is functional to adapting to new
environmental conditions and to reinforcing network
communications. For example, when a cell, such as
a lymphocyte (a primary component of host defenses),
becomes stimulated by a cytokine or another specific
antigen, it becomes ‘primed’ to express a higher number
of receptors to more compounds. Other examples of
priming are bronchial reactivity in asthmatics following
antigenic stimulation, liver induction of detoxifying
enzymes following alcohol or drug ingestion, cardiac
hypertrophy following physical exercise and increase of
synaptic strength in neurons (memory).
Homeopathic Proving
Figure 5C shows a schematic view of homeopathic proving:
in a ‘healthy’ regulating system network, an exogenous
pharmacological signal could trigger many activities which
mimic the reaction to stress. In accordance with homeo-
pathic principles, because most symptoms derive from
homeodynamic system activation, it should somehow
be possible to reproduce their activation with a compound
capable of provoking symptoms in healthy and sensitive
subjects. Theoretically, symptoms similar to natural reac-
tion can be reproduced by administering an activating
(or inhibiting) substance through homologous or hetero-
logous receptors. The resulting pattern of characteristic
signs is the ‘portrait’ of a disease involving the same
regulatory systems in reaction to a natural stressor.
Homeopathic Regulation
The traditional approach of mainstream medicine is
essentially reductionistic and mechanistic—it is based on
the identification and elimination of pathogenic factors
(for example, antibiotic therapy), on the antagonism
toward endogenous signals (such as anti-TNF antibodies)
or on inhibition of hyperactive control systems (such as
anti-inflammatory agents), or on their stimulation if
eCAM 2007;4(2) 155
ar
r
Condi t ion
A’ a
r
a
r
a
r
r
Effector
system A→A′
Effector
system A←A′
Condition
A′
Condition
A′
Homologous
receptors
Homologous
priming
Heterologous
priming
Stressor
(pathogenic factor)
Signal
Signal To other
systems
(network)
Individual
sensitivity
To other
systems
(network)
To other
systems
(network)
"Simile" signal
Feed-back
A
B
C
Heterologous
receptors
Signals from
other systems
(network)
Regulation
systema
+
+
+
+
+
+
+
+
Regulation 
system
Condition
A′
Condition
A′
Condition
A′
Condition
A′
Regulation of
homeodynamics
(healing)
Symptoms of
direct damage
A1, A2, A3...
Symptoms of
regulation
R1, R2, R3...
Symptoms of
regulation
R1, R2, R3...
Regulation
system
a
a
a
r
r
r
r
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156 Immunology and homeopathy
assuming they are inefficient (such as immunostimulatory
agents) or, finally, on substitutive therapies (such as
insulin for diabetics or bone marrow transplantation for
severe immunodeficiency). This approach works in
a number of circumstances, but when homeodynamic
loss is due to many factors or to ambiguous causes,
it becomes difficult to identify all the specific biochemical
blocks or the specific molecules that would be required.
For example, it is well documented that the psychological
profile or subtle functional disorders negatively impact
long-term health (40,66–68).
Taking into account its fundamental complexity, regula-
tion can be obtained through the similia principle, starting
with a new and holistic view of what constitutes the
vital force and its possible dynamic alterations. To quote
Hahnemann (Organon, para 29) ‘every disease (not
entirely surgical) consists only in a special, morbid, dynamic
alteration of our vital energy’. The ‘dynamic alteration of
vital energy’ can be translated in today’s terms as both
homeodynamic and communication disorders. By refer-
ence to our basic model we should distinguish two modes
of action of the simile, the first one related to acute
diseases, the second one to chronic diseases.
Acute Diseases
An acute disease (Fig. 6A) occurs when an external
pathogen damages the organism, which in turn generates
an excessive reaction, thus causing more damage—classic
examples include rhinoconjunctivitis, abscess, thrombosis,
panic attack, pneumonia, anaphylaxis, influenza and
shock. Apart from any necessary attempt to eliminate
or at least to reduce the pathogen, here the homeopathic
intervention (Fig. 6B) could assist in decreasing the risk
of excessive reaction.
This outcome could be obtained by using a remedy
which, in healthy subjects, mimics the actual symptoms
of the disease which are produced by the regulating
system. In the diseased organism, which is already
activated by the disease, the effect of ‘similar’ medicine
is not an increase of symptoms, but, on the contrary, has
the opposite effect as previously described (e.g.: non-
linearity, hormesis, initial value rule). Consequently, the
acute condition would continue its physiological course
toward healing without the risk of excessive reactions
and with fewer symptoms.
Other regulatory systems can become depressed in the
course of acute disease (not shown in the figure), causing,
for example, fatigue, anorexia, loss of concentration, etc.
In such cases, the inversion of effects of the ‘simile’ drug
would be associated with the stimulation of the affected
regulatory systems.
Chronic Diseases
When the homeodynamic upset is continuous, following
an initial reactive phase, the regulatory system may
undergo a significant change of status—it will adapt to its
altered conditions and will progressively suppress its own
sensitivity to the persistent and stronger signal (Fig. 7A).
The adaptation thus enables the system to survive the
disease in question, which would otherwise require an
excessive expenditure of energy (continual activation
of regulatory systems and of both the A–A0 and A0–A
mechanisms). This phase can be considered the major
factor of disease chronicization, as previously described
in the HPA axis (Fig. 3B). The homeodynamic displace-
ment is self-maintained by the suboptimal network
response, through desensitization of one or more
regulatory systems.
From a molecular point of view, cells can down-
regulate specific receptors for ‘a’ to the point of complete
elimination, or can reduce their affinity, or diminish
signal transduction to the effector systems (in our case,
the production of ‘r’). This phenomenon is quite specific
on the receptor level—in other words, the occupied
receptors disappear, while others either persist or at least
increase quantitatively; desensitization tends to be ago-
nist-specific. How different receptors behave in cells
exposed to a change of functional state is clearly shown
by our experiments comparing human neutrophils
isolated either from blood or from skin inflammatory
exudate of the same subjects (69). Inflammatory cells
exhibited a respiratory burst in response to fMLP and to
substance P that was 2- to 3-fold higher than the burst
exhibited by blood cells (priming). On the contrary, the
response to other stimulants such as concanavalin A was
not primed and the response to TNF-a was decreased
in exudate versus blood cells by about 50% (desensitiza-
tion). Therefore, the inflammatory cells, compared with
blood cells, appear to be at the same time primed,
unmodified and desensitized, according to the different
receptors involved.
Because the regulatory system conserves other sensitiv-
ities in the diseased state and, in all probability, also
accentuates these sensitivities (see heterologous priming),
the system can be reactivated. This is where we see the
fundamental contribution of homeopathic tradition—in
chronic disease (Fig. 7B), the homeopathic remedy,
identified as the remedy which produces symptoms
similar to those of the disease (considering its overall
course, including ‘old’ symptoms and constitutional
symptoms), would activate the regulatory system through
receptors and sensitivities other than those for ‘a’, but
which would produce the same outcome, by restoring the
‘r’ signal. This phenomenon would activate the counter-
balance mechanism A0–A. The homeopathic drug is thus
considered a functional substitute of ‘a’ to which the
system is no longer sensitive because it has adapted.
The homeopathic remedy will stimulate homeodynamic
feedback by latching onto perfectly efficient sensitivities
that are not blocked by the disease. By recalling the
medicinal effects on the healthy subjects (proving),
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one can assume that in the diseased subject these medicines
will assist in re-establishing the introduction of specific
information. With the stress factor removed, the network
will find its way (attractor) back to a healthy state.
The Homeopathic ‘Potencies’
The second major challenge of homeopathy is the use of
ultra-low doses (more precisely termed high dilutions, or
high potencies according to classic homeopathic par-
lance), i.e. those which contain virtually no molecules of
the active compound. Even if the present study is
committed to the similia principle, a brief mention of
the theories and evidence regarding how ultra-diluted
homeopathic could act is warranted. Two basic questions
need to be answered:
(a) Can a solvent, such as water or water-containing
various percentages of ethanol, incorporate and
maintain some information from the original
solute?
(b) Admitting that some pharmacological information
is endowed by homeopathic solutions, how could
it be transmitted to the body and have therapeutic
effects?
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Briefly, most of the findings converge on a non-
molecular (or ‘meta-molecular’) intelligence carried by
solvent molecules (being water or a water/alcohol
mixture), which could interact within the organism by
way of resonance with biophysical regulatory systems
(10,70–75).
The Physical Nature of the Remedy
Many studies have been conducted to offer an in-depth
explanation of the physiochemical nature of homeopathic
drugs which have been highly diluted. A number of
experimental findings and physical theories support the
possibility that water and ethanol molecules, which are
typical solvents of homeopathic drugs, are somehow
‘connected’ in a type of dynamic, self-organizing
networks, described as ‘water clusters’ (73,76–78).
These physical states of the solvent could then encode
the information necessary to activate the biological
processes, possibly on the cell membrane level.
In the process of serial dilution and succussion,
a homeopathic solution could undergo an increase of
its physical structure, similar to geometrically grand and
branched fractal images resulting from iterative
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mathematical algorithm (10,79,80). Although today such
a hypothesis is strictly speculative, recent scientific
evidence directs us to study this elusive phenomenon.
It is worth noting that laboratory models of homeopathic
dilutions show alternating activity peaks (5,32).
Homeopathic solutions, when compared with the control
solvent samples, show increased electrical conductivity
(81,82), distinct NMR signals (83), optical emissions (84)
and characteristic thermo-luminescent patterns when
undergoing electromagnetic impulses (85).
Furthermore, the concept of self-developing ‘coherent
domains’ (CD) in liquid crystals and water, has been
proposed to follow the quantum electrodynamic
(QED) theories concerning condensed matter (86–89).
The theory rests on the different behavior between the
macroscopical assemblies of identical microscopical
systems and classical microscopic interaction due to
weak forces; the differences are exalted below the
so-called critical temperature or above the ‘critical’
density. CDs are taking shape as the ‘fundamental
blocks’ for condensed matter: atoms, molecules, electrons
and nuclei tune inside blocks to a macroscopic (classical)
electromagnetic field, thus allowing the efficient fre-
quency exchange between different system’s CDs. Some
evidence suggests the effects of low-frequency electro-
magnetic fields on water (90) and on biological structures
through changes in solvent structuring: microwave
irradiated solutions modify the opening capability of
cell membrane ionic channels even if irradiation stopped
(91–93). The authors referred the phenomenon as
‘electromagnetic memory of water’.
Sensitivity, Complexity and Resonance
According to the dynamic systems theory, the whole
organism and each cell can be described as complex
systems where the ‘equilibrium’ is a special case of
attractor, the integration of a number of attractors
(94–99). As a consequence, healthy and pathological
states become interpretable as different types of attrac-
tors, which may be converted from each other by
bifurcations or critical perturbations. An important
characteristic of those attractors are their chaotic
dynamics, referred to as ‘sensitive dependence on initial
conditions and on perturbations’. Small differences of the
starting conditions or perturbations of trajectories in
the space-states produce important differences in the final
phenomena (100–102).
Future studies on fractals and deterministic chaos will
influence knowledge on physiology and pathology,
enabling the characterization of the therapeutic effects
of periodic stimuli (including physiological stress, acu-
puncture, electric pacing, psychotherapy and so on),
different pharmacological compounds (103) and highly
diluted homeopathic remedies (11,104–108). Very slight
and highly specific signals could act at unison with the
resonant recipient system (s) thus becoming ‘regulators’
of its (their) dysregulation and unbalance, where the
choice, at the bifurcation point, depends upon minor
fluctuations between order and chaos.
In this connection, the possible effect of ultra-diluted
and succussed medicines has a chance for a scientific
explanation. The disease could be regarded both
as functional or molecular-structural abnormality and
as disturbance of the overall network of electromagnetic
communications: long-range interactions act between
oscillating elements (molecules, nerve centers, organs, to
mention but a few), whose frequencies are coherent and
specific, in other words, resonant. Therefore, disease is
the disturbance of internal oscillators and their commu-
nications. Thus, a homeopathic drug might be regarded
as a small quantity of matter in which phase oscillating
elements could coherently transmit oscillatory frequen-
cies, via resonance, to both oscillating and non-linear
biological fluids or complex ‘metastable’ structures
(macromolecules, protein different conformations,
membranes, filamentous structures, receptors).
The ‘Simile’ as Heuristic Principle
In synthesis, the homeopathic simile can be re-evaluated
as a heuristic (finding) principle, a principle of biological
and clinical research which assists in finding therapeutic
strategies: in classic homeopathy, the ‘similars’ are those
compounds which generate symptoms akin to those
of the disease in all of its pathological, psychological
and physiological complexity. The administration of the
remedy to a sick organism would restore synchronism
and cooperativity in cell enzymes, metabolic cycles,
molecular feed-back loops, bioelectric potentials, with
the consequence of higher cooperativity and more
efficient energy handling.
The two approaches to system regulation—scientific/
reductionistic and homeopathic/holistic—are not conflict-
ing, but use different approaches: mainstream pharma-
cology applies a ‘structural’ analog, which is identified
as the molecule binding to specific receptors or enzymes
of the target system (if known). Classic homeopathy
applies a ‘functional’ analogue, which is identified as the
diluted compound that is able to regulate and/or to
trigger homeodynamic systems. This kind of functional
analogy, based on the similarity of symptoms, can be
exploited even if the details of the receptors or the
effector enzymes are unknown within the complex
homeodynamic networks.
Mainstream pharmacology is much more precise when
the exact mechanism of the disease is known, and specific
drugs can therefore be administered. Homeopathy could
be more effective when considering the complexity of the
disease and subtle regulations. The homeopathic
approach may be useful specifically because it does not
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focus on the cause of the disease, but on the teleonomy
of the patient’s reaction. It is therefore not to be
considered an alternative approach, but complementary
to effective drug use.
For example, some people frequently become infected
(primarily upper-respiratory infections) due to climatic
change, cold weather, stress or contact with an infected
person (in schools or hospitals). It is known that often
there is no molecular or genetic explanation which fully
justifies such an increase of susceptibility to infection.
It is obvious that the immediate cause of the infection
could be microbial, but it is also true that the whole
‘terrain’ plays an important role. Therefore, a more
logical and effective approach is one where the focus is
placed on complex response stimulation, a homeopathic
cornerstone (6,7).
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